Abstract
Identification of alterations in gene expression is an important step in understanding the development and progression of human disease. For pigmentary disorders with an unresolved hereditary component, genetic and epigenetic changes that alter the expression of genes as a direct or indirect consequence can be investigated by expression analysis. This can be of particular importance in conditions in which multiple genes are involved, as in melanoma or vitiligo (1,2). Differential display analysis is a technique that is widely used and entails semiquantitative polymerase chain reaction (PCR) amplification of 3′ ends of messenger RNA (mRNA) (3– 6). The primer sets used hybridize to the poly-A tail of mRNA on one end, and to an arbitrary countersequence on the other. Each set of primers is designed to amplify some 150 messages present in the RNA under study. These messages are subsequently separated by polyacrylamide gel electrophoresis. Using a labeled nucleotide in the PCR reaction, the intensity of each band can subsequently be compared in samples of interest. Following reamplification, confirmation, cloning, and sequencing, the fragments of interest are further analyzed. Figure 1 outlines this sequence of events. Although the length of the fragments amplified usually excludes coding regions, the 3′ noncoding regions are unique and can serve to identify the gene of interest, provided the fragment belongs to a gene or an expressed sequence tag (EST) that has previously been submitted to GenBank (7).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Welch, D. R. and Goldberg, S. F. (1997) Molecular mechanisms controlling human melanoma progression and metastasis. Pathobiology 65, 311–330.
Nordlund, J. J (1997) The epidemiology and genetics of vitiligo. Clin. Dermatol. 15, 875–878.
Liang, P. and Pardee, A. B. (1992) Display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–970.
Liang, P., Averboukh, L., Keyomarsi, K., and Pardee, A. B. (1994) Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res. 21, 3269–3275.
Mou, L., Miller, H., Li, J., Wang, E., and Chalifour, L. (1994) Improvements to the differential display method for gene analysis. Biochem. Biophys. Res. Commun. 199, 564–569.
Bauer D. Muller H. Reich J. Riedel H. Ahrenkiel V. Warthoe P. and Strauss M. 1993 Identification of differentially expressed mRNA species by an improved display technique DDRT–PCR. Nucleic Acids Res. 21] 4272–4280
Lipman, D. J. (1997) Making (anti)sense of non-coding sequence conservation. Nucleic Acids Res. 25, 3580–3583.
Kwon, B. S., Halaban, R., Kim, G. S., Usack, L., Pomerantz, S., and Haq, A. K. (1987) A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine. Mol. Biol. Med. 4, 339–355.
Dakour, J., Jimbow, K., Vinayagamoorthy, T., Luo, D., and Chen, H. (1993) Characterization of melanosome-associated proteins by establishment of monoclonal antibodies and immunoscreening of a melanoma cDNA library through an anti-melanosome antibody. Melanoma Res. 3, 331–336.
Frohmann, M. A. (1994) On beyond classic RACE (Rapid Amplification of cDNA Ends). PCR Meth. Appl. 4, 40–48.
Jiang, H., Lin, J. J., Su, Z. Z., Goldstein, N. I., and Fisher, P. B. (1995) Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11, 2477–2486.
Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microaaray. Science 270, 467–470.
Le Poole, I. C., Yang, F., Brown, T. L., Cornelius, J., Babcock, G. F., Das, P. K., and Boissy, R. E. Altered gene expression in melanocytes exposed to 4-tertiary butyl phenol (4-TBP): upregulation of the A2b adenosine receptor. J. Invest. Dermatol. 113, 725–731.
Bennett, D. C., Cooper, P. J., and Hart, I. R. (1987) A line of non-tumorigenic mouse melanocytes syngeneic with the B16 melanoma and requiring a tumor promotor for growth. Int. J. Cancer 39, 414–418.
Maiorana, A., Cavallari, V., Maiorana, M. C., Fano, R. A., Scimone, S., Fante, R., and Garbisa, S. (1992) Metastatic capacity and differentiation in murine melanoma cell lines: a morphometric study. Pathol. Res. Pract. 188, 657–662.
Ishiguro, T., Nakajima, M., Naito, M., Muto, T., and Tsuruo, T. (1996) Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res. 55, 6237–6243.
van Groningen, J. J. M., Bloemers, H. P. J., and Swart, G. W. M. (1995) Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell line with different metastatic capacity by messenger RNA differential display. Cancer Res. 55, 4109–4115.
GÓmez, L. A., Strasberg Rieber, M., and Rieber, M. (1996) PCR-mediated differential display and cloning of a melanocyte gene decreased in malignant melanoma and up-regulated with sensitization to DNA damage. DNA Cell Biol. 15, 423–427.
Hashimoto, Y., Shindo-Okada, N., Tani, M., Takeuchi, K., Toma, H., and Yokota, J. (1996) Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res. 56, 5266–5271.
Francia, G., Mitchell, S. D., Moss, S. E., Hanby, A. M., Marshall, J. F., and Hart, I. R. (1996) Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res. 56, 3855–3858.
Hildebrandt, T., Freiherr, J., Klostermann, S., Kaul, S., Zendman, A. J. W., van Muijen, G. N. P., and Weidle, U. H. (1999) Identification of URIM, a novel gene up-regulated in metastasis. Anticancer Res. 19, 525–530.
Duncan, L. M., Deeds, J., Hunter, J., Shao, J., Holmgren, L. M., Woolf, E. A., Tepper, R. I., and Shyjan, A. W. (1998) Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 58, 1515–1520.
van Groningen, J. J. M., Egmond, M. R., Bloemers, H. P. J., and Swart, G. W. M. (1997) nmd, A novel gene differentially expressed in human melanoma cell lines, encodes a new and atypical member of the family of lipases. FEBS Lett. 404, 82–86.
Vogt, T. M. M., Welsh, J., Stolz, W., Kullman, F., Jung, B., Landthaler, M., and McCleland, M. (1997) RNA fingerprinting displays UVB-specific disruption of transcriptional control in human melanocytes. Cancer Res. 57, 3554–3561.
Furumura, M., Sakai, C., Potterf, S. B., Vieira, W. D., Barsh, G. S., and Hearing, V. J. (1998) Characterization of genes modulated during pheomelanogenesis using differential display. Proc Natl Acad Sci USA 95, 7374–7378.
Giambernardi, T. A., Rodeck, U., and Klebe, R. J. (1998) Bovine serum albumin reverses inhibition of RT-PCR by melanin. BioTechniques 25, 564–566.
Smit, N. P. M., Van der Meulen, H., Koerten, H. K., Kolb, R. M., Lentjes, E. G., and Pavel, S. (1997) Melanogenesis in cultured melanocytes can be substantially influenced by L-tyrosine and L-cysteine. J. Invest. Dermatol. 109, 796–800.
Trentmann, S. M., Van der Knaap, E., and Kende, H. (1995) Alternatives to 35S as a label for the differential display of eukaryotic messenger RNA. Science 267, 1186.
Marchuk, D., Drumm, M., Saulino, A., and Collins, F. S. (1991) Construction of T-Vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res. 19, 1154.
Callard, D., Lescure, B., and Mazzolini, L. (1994) A method for the elimination of false positives generated by the mRNA differential display technique. BioTechniques 16, 1100–1103.
Wadha, R., Duncan, E., Kaul, S. C., and Reddel, R. R. (1996) An effective elimination of false positives isolated from differential display of mRNAs. Mol. Biotechnol. 6, 213–217.
Luce, M. J. and Burrows, P. D. (1998) Minimizing false positives in differential display. BioTechniques 24, 766–768, 770.
Miele, G., MacRae, L., McBride, D., Manson, J., and Clinton, M. (1998) Elimination of false positives generated through PCR re-amplification of differential display cDNA. BioTechniques 25, 138–144.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Le Poole, I., Brown, T.L. (2001). Identification of Altered Gene Expression Associated with Pigmentary Lesions by Differential Display Analysis. In: Nickoloff, B.J., Hood, L. (eds) Melanoma Techniques and Protocols. Methods in Molecular Medicine, vol 61. Humana Press. https://doi.org/10.1385/1-59259-145-0:165
Download citation
DOI: https://doi.org/10.1385/1-59259-145-0:165
Publisher Name: Humana Press
Print ISBN: 978-0-89603-684-0
Online ISBN: 978-1-59259-145-9
eBook Packages: Springer Protocols